Abstract:Microneedle arrays have been shown to be a minimally invasive method of transdermal drug delivery. However, methods to coat these arrays often require a reservoir of the active ingredient, leading to material unused and wasted. Electrospray deposition is a targeted coating method that offers a competitive alternative for coating microneedles. By architecting the charge landscape of the setup, this technology can achieve coating deposition efficiencies nearing 100%, with little to no material wasted during the coating process. A Middle East respiratory syndrome coronavirus DNA vaccine was used as the model material to assess deposition efficiency as well as the efficacy of fragile biological materials subjected to electrospray deposition. These coatings were inserted into Sprague Dawley rats where the antigen was subsequently detected and located using immunohistochemistry. This work demonstrates the capability of electrospray deposition as a highly efficient method to coat microneedles for transdermal drug delivery.

What problem does this paper attempt to address?

The main problems that this paper attempts to solve are to improve the coating efficiency of microneedle arrays (MNAs) and reduce material waste, while evaluating the effectiveness of electrospray deposition (ESD) technology in coating Middle East Respiratory Syndrome Coronavirus (MERS - CoV) DNA vaccines on microneedle arrays. Specifically: 1. **Improving coating efficiency**: Traditional microneedle array coating methods usually require a large amount of active ingredient reserves, resulting in a large amount of material waste. However, electrospray deposition technology can achieve a coating deposition efficiency close to 100% by precisely controlling the charge distribution, with almost no material waste. 2. **Protecting fragile biological materials**: The electro - dynamic force generated during the electrospray deposition process may cause irreversible damage to fragile biological materials (such as DNA vaccines). Therefore, researchers have explored how to protect the integrity of DNA vaccines during the electrospray process by adding specific excipients (such as trehalose and polystyrene - block - polyacrylic acid, PS - b - PAA). 3. **Verifying in - vivo transfection effects**: Researchers inserted microneedle arrays coated with MERS - CoV DNA vaccines into rat skin and detected the expression of antigens by immunohistochemistry to evaluate the effect of electrospray deposition technology in delivering DNA vaccines in vivo. 4. **Exploring potential applications**: Through the above research, the paper also aims to show the potential of electrospray deposition technology in preparing coated microneedle arrays, especially when distributing vaccines in resource - limited areas, without relying on cold - chain supplies, thereby improving the accessibility and cost - effectiveness of vaccines. In summary, this paper mainly focuses on improving the coating efficiency and material utilization rate of microneedle arrays through electrospray deposition technology, while evaluating its effectiveness and safety in delivering DNA vaccines.

Microneedle arrays coated with Middle East respiratory syndrome coronavirus DNA vaccine via electrospray deposition

Dissolving Microneedle Arrays As a Hepatitis B Vaccine Delivery System Adjuvanted by APC-Targeted Poly (Lactic-Co-glycolic Acid) (PLGA) Nanoparticles

Microneedle technology for potential SARS-CoV-2 vaccine delivery

Separable Microneedle Patch to Protect and Deliver DNA Nanovaccines Against COVID-19

Smart microneedle coatings for controlled delivery and biomedical analysis

Coated Porous Microneedles for Effective Intradermal Immunization with Split Influenza Vaccine

Microneedle Coating Techniques for Transdermal Drug Delivery

Microneedle Coating Methods: A Review with a Perspective

Production of dissolvable microneedles using an atomised spray process: Effect of microneedle composition on skin penetration

Microneedle arrays as medical devices for enhanced transdermal drug delivery

Electroplated microneedle array for biomedical applications

Cyclodextrin microneedles for the delivery of a nanoparticle-based peptide antigen vaccine

Fully embeddable chitosan microneedles as a sustained release depot for intradermal vaccination

A Gene-Coated Microneedle Patch Based on Industrialized Ultrasonic Spraying Technology with a Polycation Vector to Improve Antitumor Efficacy.

The Fabrication and Property of a Novel Coated Out-of-plane Microneedle Arrays

A Flexible Microneedle Array As Low-Voltage Electroporation Electrodes for in Vivo DNA and Sirna Delivery.

Ex vivo evaluation of a microneedle array device for transdermal application

Intradermal delivery of vaccine nanoparticles using hollow microneedle array generates enhanced and balanced immune response

Leveraging novel innovative thermoresponsive polymers in microneedles for targeted intradermal deposition

Efficient Delivery of Nucleic Acid Molecules into Skin by Combined Use of Microneedle Roller and Flexible Interdigitated Electroporation Array.

A Facile Method for High-Throughput Screening of Drug-Eluting Coatings in Droplet Microarrays Based on Ultrasonic Spray Deposition.